| Address:
|
3240 WHIPPLE
ROAD |
| City: |
UNION CITY |
|
State: |
CA |
|
Zip Code: |
94587 |
| Telephone: |
(510) 675-6500 |
|
Description of Business
|
Primary SIC Code:
3829 |
| (As filed with the SEC)
|
|
|
Abaxis, Inc. ("Abaxis," "us" or "we") develops, manufactures, markets and sells
portable blood analysis systems for use in the human or veterinary patient-care
setting to provide clinicians with rapid blood constituent measurements. Abaxis
was incorporated in California in 1989. Our principal offices are located at
3240 Whipple Road, Union City, California 94587. Our telephone number is (510)
675-6500 and our Internet address is www.abaxis.com. Our common stock trades on
the NASDAQ Global Market under the symbol "ABAX."
OUR INDUSTRY: IN VITRO DIAGNOSTIC TESTING
We believe that a key element of the patient-centered, cost-constrained health
care system will be the availability of blood analysis systems in the patient
care setting that are easily and reliably operated by caregivers and that
provide accurate, real time results to enable rapid clinical decisions. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 12/2011 | 0.47 | NA | 58.87 | | 09/2011 | 0.56 | NA | 40.91 | | 06/2011 | 0.58 | NA | 46.98 | | 03/2011 | 0.64 | NA | 45.06 | | 12/2010 | 0.61 | NA | 44.02 | | 09/2010 | 0.59 | NA | 39.15 | | 06/2010 | 0.57 | NA | 37.60 | | 03/2010 | 0.58 | NA | 46.88 |
Key Financial Ratios and Statistics |
FYE:
03/31 |
| Profitability |
2011 |
Leverage |
2011 |
| Net Inc/Comm Equity | 0.11 | Total Liab/Total Assets | 0.10 | | Net Inc/Total Assets | 0.08 | Total Liab/Inv Cap | 0.11 | | Net Inc/Inv Cap | 0.08 | Total Liab/Comm Equity | 0.15 | | Pretax Inc/Net Sales | 0.16 | Interest Coverage Ratio | NA | | Net Inc/Net Sales | 0.10 | Curr Debt/Equity | NA | | Cash Flow/Net Sales | 0.11 | LTD/Equity | 0.00 | | SG&A/NetSales | 0.32 | Total Debt/Equity | 0.00 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 4.89 | Quick Ratio | 6.31 | | Inventory Turnover | 3.29 | Current Ratio | 7.51 | | Inventory Day Sales | 0.01 | Net Rec/Curr Assets | 0.25 | | Net Sales/Work Cap | 1.34 | Inv/Curr Assets | 0.16 | | Net Sales/PP&E | 7.32 | | |
Income Statement (Millions) |
| |
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Total Revenues(Net Sales)
|
40.03
|
36.00
|
37.54
|
35.91
|
|
Cost of Goods Sold
|
18.00
|
16.78
|
17.09
|
16.10
|
|
Selling & Admin Exps
|
13.83
|
12.57
|
12.50
|
11.03
|
|
Operating Income
|
5.18
|
3.20
|
5.30
|
5.83
|
|
Interest Exp
|
NA
|
NA
|
NA
|
NA
|
|
Pretax Income
|
5.24
|
3.49
|
5.70
|
5.88
|
|
Other Income
|
NA
|
NA
|
NA
|
NA
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
3.32
|
2.21
|
3.37
|
3.84
|
|
Assets
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Cash & Short Term Investments
|
55.64
|
61.76
|
69.45
|
75.54
|
|
Receivables - Total
|
30.54
|
29.85
|
31.30
|
28.00
|
|
Inventories - Total
|
19.11
|
18.61
|
19.81
|
19.59
|
|
Total Current Assets
|
110.36
|
114.08
|
124.06
|
128.38
|
|
Net Property, Plant & Equipment
|
22.91
|
21.53
|
19.64
|
16.95
|
|
Total Assets
|
170.30
|
190.87
|
188.26
|
181.33
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
17.01
|
15.53
|
15.57
|
15.19
|
|
Debt in Current Liabilities
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Liabilities
|
18.12
|
16.57
|
16.52
|
16.14
|
|
Long-Term Debt
|
0.83
|
0.73
|
0.75
|
NA
|
|
Total Liabilities
|
21.90
|
20.01
|
19.61
|
18.38
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Common Stock
|
106.26
|
132.05
|
132.04
|
129.72
|
|
Retained Earnings
|
42.14
|
38.82
|
36.61
|
33.23
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
148.40
|
170.87
|
168.65
|
162.95
|
|
Total Liabilities and Stockholders' Equity
|
170.30
|
190.87
|
188.26
|
181.33
|
Cash Flow Summary (Millions) |
|
Categories
|
9/30/2011
|
6/30/2011
|
3/31/2011
|
12/31/2010
|
|
Net Cash Provided by Operating Activities
|
5.49
|
7.19
|
5.69
|
3.72
|
|
Net Cash Provided by Investing Activities
|
14.68
|
-4.49
|
-7.56
|
-3.02
|
|
Net Cash Provided by Financing Activities
|
-27.12
|
-1.16
|
1.59
|
2.22
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 03/2007 | 86.22 | 10.07 | 0.46 | | 03/2008 | 100.55 | 12.50 | 0.56 | | 03/2009 | 105.56 | 12.01 | 0.54 | | 03/2010 | 124.56 | 13.02 | 0.58 | | 03/2011 | 143.68 | 14.54 | 0.64 | | Growth Rates | 13.62 | 9.60 | 8.61 |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 12/31/11 | 126 | 20,463 | 94.40 |
|
Report Date :
2/6/2012
 Copyright
2012, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|